Listed

Galectin Therapeutics Inc

GALTNasdaqCIK 1133416HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$4.0m, Q2 FY2026
Net income−$9.1m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Research and development$m7.7Research and development, Q3 FY2023, three months to 2023-09-30$7.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-14, accession 0001140361-24-046726.Report this figure8.2Research and development, Q4 FY2023, three months to 2023-12-31$8.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-31, accession 0001140361-25-011169. Derived: 12-month figure less the 9-month figure.Report this figure8.1Research and development, Q1 FY2024, three months to 2024-03-31$8.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-15, accession 0001140361-25-019149.Report this figure9.8Research and development, Q2 FY2024, three months to 2024-06-30$9.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-14, accession 0001140361-25-031039.Report this figure7.6Research and development, Q3 FY2024, three months to 2024-09-30$7.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-14, accession 0001140361-25-042116.Report this figure11.1Research and development, Q4 FY2024, three months to 2024-12-31$11.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-31, accession 0001140361-26-012155. Derived: 12-month figure less the 9-month figure.Report this figure6.5Research and development, Q1 FY2025, three months to 2025-03-31$6.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-15, accession 0001140361-26-021495.Report this figure3.3Research and development, Q2 FY2025, three months to 2025-06-30$3.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-14, accession 0001140361-26-032945.Report this figure2.6Research and development, Q3 FY2025, three months to 2025-09-30$2.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-14, accession 0001140361-25-042116.Report this figure1.9Research and development, Q4 FY2025, three months to 2025-12-31$1.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-31, accession 0001140361-26-012155. Derived: 12-month figure less the 9-month figure.Report this figure2.2Research and development, Q1 FY2026, three months to 2026-03-31$2.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-15, accession 0001140361-26-021495.Report this figure2.1Research and development, Q2 FY2026, three months to 2026-06-30$2.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-14, accession 0001140361-26-032945.Report this figure
Operating income$m(9.2)Operating income, Q3 FY2023, three months to 2023-09-30−$9.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-14, accession 0001140361-24-046726.Report this figure(9.6)Operating income, Q4 FY2023, three months to 2023-12-31−$9.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-31, accession 0001140361-25-011169. Derived: 12-month figure less the 9-month figure.Report this figure(9.6)Operating income, Q1 FY2024, three months to 2024-03-31−$9.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-15, accession 0001140361-25-019149.Report this figure(11.3)Operating income, Q2 FY2024, three months to 2024-06-30−$11.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-14, accession 0001140361-25-031039.Report this figure(9.1)Operating income, Q3 FY2024, three months to 2024-09-30−$9.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001140361-25-042116.Report this figure(12.4)Operating income, Q4 FY2024, three months to 2024-12-31−$12.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-31, accession 0001140361-26-012155. Derived: 12-month figure less the 9-month figure.Report this figure(7.9)Operating income, Q1 FY2025, three months to 2025-03-31−$7.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001140361-26-021495.Report this figure(4.6)Operating income, Q2 FY2025, three months to 2025-06-30−$4.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001140361-26-032945.Report this figure(4.2)Operating income, Q3 FY2025, three months to 2025-09-30−$4.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001140361-25-042116.Report this figure(3.4)Operating income, Q4 FY2025, three months to 2025-12-31−$3.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-31, accession 0001140361-26-012155. Derived: 12-month figure less the 9-month figure.Report this figure(4.1)Operating income, Q1 FY2026, three months to 2026-03-31−$4.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001140361-26-021495.Report this figure(4.0)Operating income, Q2 FY2026, three months to 2026-06-30−$4.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001140361-26-032945.Report this figure
Interest expense$m0.8Interest expense, Q3 FY2023, three months to 2023-09-30$835.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-13, accession 0001140361-23-052729.Report this figure0.8Interest expense, Q4 FY2023, three months to 2023-12-31$847.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-03-29, accession 0001140361-24-016452. Derived: 12-month figure less the 9-month figure.Report this figure1.1Interest expense, Q1 FY2024, three months to 2024-03-31$1.1m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-15, accession 0001140361-24-026105.Report this figure1.3Interest expense, Q2 FY2024, three months to 2024-06-30$1.3m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-14, accession 0001140361-25-031039.Report this figure1.5Interest expense, Q3 FY2024, three months to 2024-09-30$1.5m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-14, accession 0001140361-25-042116.Report this figure1.7Interest expense, Q4 FY2024, three months to 2024-12-31$1.7m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-31, accession 0001140361-26-012155. Derived: 12-month figure less the 9-month figure.Report this figure1.7Interest expense, Q1 FY2025, three months to 2025-03-31$1.7m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-15, accession 0001140361-26-021495.Report this figure1.8Interest expense, Q2 FY2025, three months to 2025-06-30$1.8m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-14, accession 0001140361-26-032945.Report this figure1.8Interest expense, Q3 FY2025, three months to 2025-09-30$1.8m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-14, accession 0001140361-25-042116.Report this figure1.9Interest expense, Q4 FY2025, three months to 2025-12-31$1.9m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-31, accession 0001140361-26-012155. Derived: 12-month figure less the 9-month figure.Report this figure2.0Interest expense, Q1 FY2026, three months to 2026-03-31$2.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-15, accession 0001140361-26-021495.Report this figure2.0Interest expense, Q2 FY2026, three months to 2026-06-30$2.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-14, accession 0001140361-26-032945.Report this figure
Net income$m(10.4)Net income, Q3 FY2023, three months to 2023-09-30−$10.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-14, accession 0001140361-24-046726.Report this figure(10.0)Net income, Q4 FY2023, three months to 2023-12-31−$10.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-31, accession 0001140361-25-011169. Derived: 12-month figure less the 9-month figure.Report this figure(11.5)Net income, Q1 FY2024, three months to 2024-03-31−$11.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-15, accession 0001140361-25-019149.Report this figure(12.4)Net income, Q2 FY2024, three months to 2024-06-30−$12.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-14, accession 0001140361-25-031039.Report this figure(11.2)Net income, Q3 FY2024, three months to 2024-09-30−$11.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001140361-25-042116.Report this figure(12.0)Net income, Q4 FY2024, three months to 2024-12-31−$12.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001140361-26-012155. Derived: 12-month figure less the 9-month figure.Report this figure(9.6)Net income, Q1 FY2025, three months to 2025-03-31−$9.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-15, accession 0001140361-26-021495.Report this figure(7.5)Net income, Q2 FY2025, three months to 2025-06-30−$7.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001140361-26-032945.Report this figure(8.2)Net income, Q3 FY2025, three months to 2025-09-30−$8.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001140361-25-042116.Report this figure(5.5)Net income, Q4 FY2025, three months to 2025-12-31−$5.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001140361-26-012155. Derived: 12-month figure less the 9-month figure.Report this figure(5.0)Net income, Q1 FY2026, three months to 2026-03-31−$5.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-15, accession 0001140361-26-021495.Report this figure(9.1)Net income, Q2 FY2026, three months to 2026-06-30−$9.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001140361-26-032945.Report this figure
Diluted EPS$ per share(0.24)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.24 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-14, accession 0001140361-24-046726.Report this figurenot reported(0.19)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-15, accession 0001140361-25-019149.Report this figure(0.20)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-14, accession 0001140361-25-031039.Report this figure(0.18)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.18 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001140361-25-042116.Report this figurenot reported(0.15)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.15 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001140361-26-021495.Report this figure(0.12)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-14, accession 0001140361-26-032945.Report this figure(0.13)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001140361-25-042116.Report this figurenot reported(0.08)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001140361-26-021495.Report this figure(0.14)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-14, accession 0001140361-26-032945.Report this figure
Basic EPS$ per share(0.24)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.24 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-14, accession 0001140361-24-046726.Report this figurenot reported(0.19)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.19 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-15, accession 0001140361-25-019149.Report this figure(0.20)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.20 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-14, accession 0001140361-25-031039.Report this figure(0.18)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.18 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-14, accession 0001140361-25-042116.Report this figurenot reported(0.15)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.15 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-15, accession 0001140361-26-021495.Report this figure(0.12)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-14, accession 0001140361-26-032945.Report this figure(0.13)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-14, accession 0001140361-25-042116.Report this figurenot reported(0.08)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.08 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-15, accession 0001140361-26-021495.Report this figure(0.14)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-14, accession 0001140361-26-032945.Report this figure

Balance sheet

Cash and equivalents$13.3m, Q2 FY2026
Shareholders' equity−$138.6m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m20.4Cash and equivalents, Q3 FY2023, at 2023-09-30$20.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-13, accession 0001140361-23-052729.Report this figure25.7Cash and equivalents, FY2023, at 2023-12-31$25.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-31, accession 0001140361-25-011169.Report this figure23.6Cash and equivalents, Q1 FY2024, at 2024-03-31$23.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-15, accession 0001140361-24-026105.Report this figure25.6Cash and equivalents, Q2 FY2024, at 2024-06-30$25.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-13, accession 0001140361-24-036937.Report this figure27.1Cash and equivalents, Q3 FY2024, at 2024-09-30$27.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-14, accession 0001140361-24-046726.Report this figure15.1Cash and equivalents, FY2024, at 2024-12-31$15.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-31, accession 0001140361-26-012155.Report this figure7.4Cash and equivalents, Q1 FY2025, at 2025-03-31$7.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-15, accession 0001140361-25-019149.Report this figure13.8Cash and equivalents, Q2 FY2025, at 2025-06-30$13.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-14, accession 0001140361-25-031039.Report this figure11.5Cash and equivalents, Q3 FY2025, at 2025-09-30$11.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-14, accession 0001140361-25-042116.Report this figure17.7Cash and equivalents, FY2025, at 2025-12-31$17.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-14, accession 0001140361-26-032945.Report this figure14.1Cash and equivalents, Q1 FY2026, at 2026-03-31$14.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-15, accession 0001140361-26-021495.Report this figure13.3Cash and equivalents, Q2 FY2026, at 2026-06-30$13.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-14, accession 0001140361-26-032945.Report this figure
Current assets$m21.6Current assets, Q3 FY2023, at 2023-09-30$21.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-13, accession 0001140361-23-052729.Report this figure27.7Current assets, FY2023, at 2023-12-31$27.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-31, accession 0001140361-25-011169.Report this figure25.5Current assets, Q1 FY2024, at 2024-03-31$25.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-15, accession 0001140361-24-026105.Report this figure27.3Current assets, Q2 FY2024, at 2024-06-30$27.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-13, accession 0001140361-24-036937.Report this figure28.7Current assets, Q3 FY2024, at 2024-09-30$28.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-14, accession 0001140361-24-046726.Report this figure17.3Current assets, FY2024, at 2024-12-31$17.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-31, accession 0001140361-26-012155.Report this figure9.3Current assets, Q1 FY2025, at 2025-03-31$9.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-15, accession 0001140361-25-019149.Report this figure15.4Current assets, Q2 FY2025, at 2025-06-30$15.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-14, accession 0001140361-25-031039.Report this figure12.7Current assets, Q3 FY2025, at 2025-09-30$12.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-14, accession 0001140361-25-042116.Report this figure19.4Current assets, FY2025, at 2025-12-31$19.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-14, accession 0001140361-26-032945.Report this figure15.7Current assets, Q1 FY2026, at 2026-03-31$15.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-15, accession 0001140361-26-021495.Report this figure14.7Current assets, Q2 FY2026, at 2026-06-30$14.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-14, accession 0001140361-26-032945.Report this figure
Total assets$m22.2Total assets, Q3 FY2023, at 2023-09-30$22.2m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-13, accession 0001140361-23-052729.Report this figure28.2Total assets, FY2023, at 2023-12-31$28.2m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-31, accession 0001140361-25-011169.Report this figure25.9Total assets, Q1 FY2024, at 2024-03-31$25.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-15, accession 0001140361-24-026105.Report this figure27.7Total assets, Q2 FY2024, at 2024-06-30$27.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-13, accession 0001140361-24-036937.Report this figure29.0Total assets, Q3 FY2024, at 2024-09-30$29.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-14, accession 0001140361-24-046726.Report this figure17.5Total assets, FY2024, at 2024-12-31$17.5m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-31, accession 0001140361-26-012155.Report this figure9.5Total assets, Q1 FY2025, at 2025-03-31$9.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-15, accession 0001140361-25-019149.Report this figure15.6Total assets, Q2 FY2025, at 2025-06-30$15.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-14, accession 0001140361-25-031039.Report this figure12.9Total assets, Q3 FY2025, at 2025-09-30$12.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-14, accession 0001140361-25-042116.Report this figure19.5Total assets, FY2025, at 2025-12-31$19.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-14, accession 0001140361-26-032945.Report this figure15.8Total assets, Q1 FY2026, at 2026-03-31$15.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-15, accession 0001140361-26-021495.Report this figure14.8Total assets, Q2 FY2026, at 2026-06-30$14.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-14, accession 0001140361-26-032945.Report this figure
Current liabilities$m10.5Current liabilities, Q3 FY2023, at 2023-09-30$10.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-13, accession 0001140361-23-052729.Report this figure15.7Current liabilities, FY2023, at 2023-12-31$15.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-31, accession 0001140361-25-011169.Report this figure12.6Current liabilities, Q1 FY2024, at 2024-03-31$12.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-15, accession 0001140361-24-026105.Report this figure14.6Current liabilities, Q2 FY2024, at 2024-06-30$14.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-13, accession 0001140361-24-036937.Report this figure25.3Current liabilities, Q3 FY2024, at 2024-09-30$25.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-14, accession 0001140361-24-046726.Report this figure35.4Current liabilities, FY2024, at 2024-12-31$35.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-31, accession 0001140361-26-012155.Report this figure111Current liabilities, Q1 FY2025, at 2025-03-31$110.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-15, accession 0001140361-25-019149.Report this figure10.8Current liabilities, Q2 FY2025, at 2025-06-30$10.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-14, accession 0001140361-25-031039.Report this figure136Current liabilities, Q3 FY2025, at 2025-09-30$136.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-14, accession 0001140361-25-042116.Report this figure8.0Current liabilities, FY2025, at 2025-12-31$8.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-14, accession 0001140361-26-032945.Report this figure7.3Current liabilities, Q1 FY2026, at 2026-03-31$7.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-15, accession 0001140361-26-021495.Report this figure152Current liabilities, Q2 FY2026, at 2026-06-30$151.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-14, accession 0001140361-26-032945.Report this figure
Total liabilities$m73.0Total liabilities, Q3 FY2023, at 2023-09-30$73.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-13, accession 0001140361-23-052729.Report this figure88.4Total liabilities, FY2023, at 2023-12-31$88.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-31, accession 0001140361-25-011169.Report this figure97.0Total liabilities, Q1 FY2024, at 2024-03-31$97.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-15, accession 0001140361-24-026105.Report this figure110Total liabilities, Q2 FY2024, at 2024-06-30$109.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-13, accession 0001140361-24-036937.Report this figure121Total liabilities, Q3 FY2024, at 2024-09-30$121.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-14, accession 0001140361-24-046726.Report this figure121Total liabilities, FY2024, at 2024-12-31$120.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-31, accession 0001140361-26-012155.Report this figure122Total liabilities, Q1 FY2025, at 2025-03-31$121.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-15, accession 0001140361-25-019149.Report this figure133Total liabilities, Q2 FY2025, at 2025-06-30$132.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-14, accession 0001140361-25-031039.Report this figure136Total liabilities, Q3 FY2025, at 2025-09-30$136.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-14, accession 0001140361-25-042116.Report this figure146Total liabilities, FY2025, at 2025-12-31$145.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-14, accession 0001140361-26-032945.Report this figure146Total liabilities, Q1 FY2026, at 2026-03-31$146.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-15, accession 0001140361-26-021495.Report this figure152Total liabilities, Q2 FY2026, at 2026-06-30$151.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-14, accession 0001140361-26-032945.Report this figure
Shareholders' equity$m(52.6)Shareholders' equity, Q3 FY2023, at 2023-09-30−$52.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-14, accession 0001140361-24-046726.Report this figure(62.0)Shareholders' equity, FY2023, at 2023-12-31−$62.0m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-31, accession 0001140361-26-012155.Report this figure(44.4)Shareholders' equity, Q1 FY2024, at 2024-03-31−$44.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-14, accession 0001140361-25-031039.Report this figure(83.9)Shareholders' equity, Q2 FY2024, at 2024-06-30−$83.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-14, accession 0001140361-25-042116.Report this figure(94.2)Shareholders' equity, Q3 FY2024, at 2024-09-30−$94.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-14, accession 0001140361-25-042116.Report this figure(105)Shareholders' equity, FY2024, at 2024-12-31−$104.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001140361-26-032945.Report this figure(114)Shareholders' equity, Q1 FY2025, at 2025-03-31−$114.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001140361-26-032945.Report this figure(119)Shareholders' equity, Q2 FY2025, at 2025-06-30−$118.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001140361-26-032945.Report this figure(125)Shareholders' equity, Q3 FY2025, at 2025-09-30−$125.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-14, accession 0001140361-25-042116.Report this figure(128)Shareholders' equity, FY2025, at 2025-12-31−$127.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001140361-26-032945.Report this figure(132)Shareholders' equity, Q1 FY2026, at 2026-03-31−$132.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001140361-26-032945.Report this figure(139)Shareholders' equity, Q2 FY2026, at 2026-06-30−$138.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001140361-26-032945.Report this figure

Cash flow

Operating cash flow−$2.4m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(7.6)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$7.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-14, accession 0001140361-24-046726. Derived: 9-month figure less the 6-month figure.Report this figure(4.7)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$4.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-31, accession 0001140361-25-011169. Derived: 12-month figure less the 9-month figure.Report this figure(12.1)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$12.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-15, accession 0001140361-25-019149.Report this figure(8.3)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$8.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-14, accession 0001140361-25-031039. Derived: 6-month figure less the 3-month figure.Report this figure(8.5)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$8.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001140361-25-042116. Derived: 9-month figure less the 6-month figure.Report this figure(12.8)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$12.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001140361-26-012155. Derived: 12-month figure less the 9-month figure.Report this figure(7.7)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$7.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001140361-26-021495.Report this figure(6.6)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$6.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-14, accession 0001140361-26-032945. Derived: 6-month figure less the 3-month figure.Report this figure(3.5)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$3.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001140361-25-042116. Derived: 9-month figure less the 6-month figure.Report this figure(6.0)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$6.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001140361-26-012155. Derived: 12-month figure less the 9-month figure.Report this figure(3.9)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$3.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001140361-26-021495.Report this figure(2.4)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$2.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-14, accession 0001140361-26-032945. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)65.88m, Q2 FY2026
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares59.4Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3059,396,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-13, accession 0001140361-23-052729.Report this figure59.5Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3159,480,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-15, accession 0001140361-24-026105.Report this figure59.6Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3059,582,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-13, accession 0001140361-24-036937.Report this figure59.7Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3059,704,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-14, accession 0001140361-24-046726.Report this figure62.0Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3161,976,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-15, accession 0001140361-25-019149.Report this figure62.2Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3062,233,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-14, accession 0001140361-25-031039.Report this figure62.3Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3062,278,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-14, accession 0001140361-25-042116.Report this figure63.2Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3163,204,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-15, accession 0001140361-26-021495.Report this figure63.4Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3063,447,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-14, accession 0001140361-26-032945.Report this figure64.2Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3064,205,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-14, accession 0001140361-25-042116.Report this figure65.8Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3165,782,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-15, accession 0001140361-26-021495.Report this figure65.9Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3065,875,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-14, accession 0001140361-26-032945.Report this figure

Shares outstanding: 100.85mShares outstanding, period not labelled, at 2026-08-06100,849,644 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-14, accession 0001140361-26-032945.Report this figure at Aug 6, 2026, from the cover of the 10-Q filed Aug 14, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. Listed shows no prices and gives no investment advice.